Masashi Iijima, Kazuyoshi Shigehara, Kazuhiro Sugimoto, Izumi Kouji, Masato Fukushima, Yuji Maeda, Hiroyuki Konaka, Atsushi Mizokami, Eitetsu Koh, Mikio Namiki
We report a case of myelodysplastic syndrome (MDS) treated effectively with testosterone enanthate. A 70-year-old man was diagnosed with low-risk MDS in 1998, and he was first given methenolone acetate orally because of gradual progression of anemia and thrombocytopenia. However, this treatment was not effective, so we changed the treatment to testosterone enanthate because of his symptoms with late-onset hypogonadism. Three months after testosterone replacement therapy (TRT), anemia and thrombocytopenia had improved, and mean platelet count and hemoglobin had significant increases from 2...
June 2011: International Journal of Urology: Official Journal of the Japanese Urological Association